Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8540 ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8540 ...

The global market for acute migraine treatment is on a steady growth trajectory, with sales expected to rise from USD 2,700.7 million in 2024 to USD 4,194.1 million by 2034, reflecting a CAGR of 4.5% ...

The Federal Circuit’s refusal to reconsider its ruling forcing Teva to delist asthma-inhaler patents from the FDA’s Orange ...

In our previous articles, we reported that the Federal Circuit affirmed the district court’s decision on December 20, 2024 ...

Teva Pharmaceuticals filed a patent infringement lawsuit against Amneal Pharmaceuticals alleging that their generic version of ...

Federal Circuit says only patents claiming the active ingredient of a drug are eligible for listing | Injunction against Teva temporarily paused in January pending the appeal court’s decision to ...

Teva Pharmaceutical Industries Ltd. failed to convince the Federal Circuit to reconsider a December ruling that five patents related to its ProAir HFA asthma inhaler must be delisted from the FDA’s ...

Medically reviewed by Brian Bezack, DO Over-the-counter (OTC) inhalers are not approved for treating chronic obstructive ...